跳至主要内容
临床试验/NCT06972953
NCT06972953进行中(未招募)不适用

NEUROvascular NAVgation With Remotely Controlled Deflectable Guidewire, Study I (NeuroNAV Study I)

Artiria Medical2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年6月16日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30
试验地点
2
主要终点
Performance

研究概览

简要总结

The aim of the study is to confirm the safe and successful use of the SmartGUIDE guidewire, when used in neuro interventions. The performance of the SmartGUIDE guidewire in terms of safe and successful navigation within the neurovasculature will be compared to standard of care guidewire on the market.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years of age
  • Informed consent signed by the patient
  • Confirmed cerebral unruptured aneurysm treatable via transcatheter approach

排除标准

  • Pregnancy or lactation
  • Known disorder of vascular fragility with propensity to vascular injury (e.g., Ehlers-Danlos syndrome)
  • Known prior vascular stenosis or dissection or injury to vessels intended to be catheterized during study procedures
  • Acute phase myocardial infarction or uncontrolled cardiac arrhythmia
  • Uncontrolled serum electrolyte imbalance
  • Bleeding disorder which limits the use of antiplatelet and/or anticoagulant therapy
  • Known contraindication to intravascular contrast material that cannot be adequately controlled with pre-medication
  • Known hypersensitivity to Nickel
  • Subjects currently enrolled in another investigational device or drug study that clinically interferes with the current study endpoints

结局指标

主要结局

Performance

时间窗: During index procedure

Intra-procedural technical success defined as successful navigation of device to the target vessel without need for shaping by hand, removal or exchange.

次要结局

  • Usability(During index procedure)
  • Procedural times(During index procedure)
  • Intra-procedural device deficiencies(During index procedure)
  • Intra-procedural adverse events(During index procedure and up to 48 hours post procedure)

研究者

发起方
Artiria Medical
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验